Cytokines decrease sGC in pulmonary artery smooth muscle cells via NO-dependent and NO-independent mechanisms

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 280, Issue 2 24-2, 2001, Pages

  Takata, Masao ^b   Filippov, Galina ^b   Liu, Heling ^b   Ichinose, Fumito ^b   Janssens, Stefan ^b   Bloch, Donald B ^b   Bloch, Kenneth D ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

Guanosine 3 ,5 cyclic monophosphate; Interleukin 1 ; Nitric oxide; Tumor necrosis factor

Indexed keywords

COMPLEMENTARY DNA; CYCLIC GMP; CYTOKINE; GUANYLATE CYCLASE; INTERLEUKIN 1BETA; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GENE EXPRESSION; IMMUNOMODULATION; LUNG ARTERY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; RAT; VASCULAR SMOOTH MUSCLE;

EID: 0035007478     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.2001.280.2.l272     Document Type: Article

References (22)

1. Bloch KD, Filippov G, Sanchez LS, Nakane M, and de la Monte SM. Pulmonary soluble guanylate cyclase, a nitric oxide receptor, is increased during the perinatal period. Am J Physiol Lung Cell Mol Physiol 272: L400-L406, 1997.
2. Chomczynski P and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
3. Filippov G, Bloch DB, and Bloch KD. Nitric oxide decreases stability of mRNAs encoding soluble guanylate cyclase subunits in rat pulmonary artery smooth muscle cells. J Clin Invest 100: 942-948, 1997.
4. Fullerton DA, McIntyre RC Jr, Hahn AR, Agrafojo J, Koike K, Meng X, Banerjee A, and Harken AH. Dysfunction of cGMP-mediated pulmonary vasorelaxation in endotoxin-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol 268: L1029-L1035, 1995.
5. Hevel JM and Marletta MA. Nitric-oxide synthase assays. Methods Enzymol 233: 250-258, 1994.
6. Keinanen R, Vartiainen N, and Koistinaho J. Molecular cloning and characterization of the rat inducible nitric oxide synthase (iNOS) gene. Gene 234: 297-305, 1999.
7. Kloss S, Bouloumie A, and Mulsch A. Aging and chronic hypertension decrease expression of rat aortic soluble guanylyl cyclase. Hypertension 35: 43-47, 2000.
8. Liu H, Force T, and Bloch KD. Nerve growth factor decreases soluble guanylate cyclase in rat pheochromocytoma PC12 cells. J Biol Chem 272: 6038-6043, 1997.
9. Macmicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, Trumbauer M, Stevens K, Xie QW, Sokol K, and Hutchinson N. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81: 641-650, 1995.
10. Mittal CK. Determination of adenylate cyclase and guanylate cyclase activities in cells of the immune system. Methods Enzymol 132: 422-428, 1986.
11. Nakane M, Arai K, Saheki S, Kuno T, Buechler W, and Murad F. Molecular cloning and expression of cDNAs coding for soluble guanylate cyclase from rat lung. J Biol Chem 265: 16841-16845, 1990.
12. Nathan C and Xie QW. Nitric oxide synthases: roles, tolls, and controls. Cell 78: 915-918, 1994.
13. Papapetropoulos A, Abou-Mohamed G, Marczin N, Murad F, Caldwell RW, and Catravas JD. Downregulation of nitro-vasodilator-induced cyclic GMP accumulation in cells exposed to endotoxin or interleukin-1 beta. Br J Pharmacol 118: 1359-1366, 1996.
14. Papapetropoulos A, Go CY, Murad F, and Catravas JD. Mechanisms of tolerance to sodium nitroprusside in rat cultured aortic smooth muscle cells. Br J Pharmacol 117: 147-155, 1996.
15. Papapetropoulos A, Marczin N, Mora G, Milici A, Murad F, and Catravas JD. Regulation of vascular smooth muscle soluble guanylate cyclase activity, mRNA, and protein levels by cAMP-elevating agents. Hypertension 26: 696-704, 1995.
16. Sambrook J, Fritsh EF, and Maniatis T. Molecular Cloning: A Laboratory Manual (2nd ed.). Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
17. Scott WS and Nakayama DK. Escherichia coli lipopolysaccharide downregulates soluble guanylate cyclase in pulmonary artery smooth muscle. J Surg Res 80: 309-314, 1998.
18. Scott WS and Nakayama DK. Sustained nitric oxide exposure decreases soluble guanylate cyclase mRNA and enzyme activity in pulmonary artery smooth muscle. J Surg Res 79: 66-70, 1998.
19. Shimouchi A, Janssens SP, Bloch DB, Zapol WM, and Bloch KD. cAMP regulates soluble guanylate cyclase β1-subunit gene expression in RFL-6 rat fetal lung fibroblasts. Am J Physiol Lung Cell Mol Physiol 265: L456-L461, 1993.
20. Thiemermann C. Nitric oxide and septic shock. Gen Pharmacol 29: 159-166, 1997.
21. Ujiie K, Hogarth L, Danziger R, Drewett JG, Yuen PS, Pang IH, and Star RA. Homologous and heterologous desensitization of a guanylyl cyclase-linked nitric oxide receptor in cultured rat medullary interstitial cells. J Pharmacol Exp Ther 270: 761-767, 1994.
22. Yu FS, Lee SL, Lanzillo JJ, and Fanburg BL. Endothelial cell inhibition of hypoxia-induced stimulation of serotonin uptake by vascular smooth muscle cells. Am Rev Respir Dis 139: 1144-1148, 1989.